Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine in Colorectal Cancer Before Surgery
NCT06225011Phase 1Recruiting
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Mar 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fluoxetine in colorectal adenocarcinoma, sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoint: Immune cell composition and microenvironment. Started Mar 2025; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT06225011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06225011.